lu 25-109 has been researched along with lithium chloride in 1 studies
| Studies (lu 25-109) | Trials (lu 25-109) | Recent Studies (post-2010) (lu 25-109) | Studies (lithium chloride) | Trials (lithium chloride) | Recent Studies (post-2010) (lithium chloride) |
|---|---|---|---|---|---|
| 14 | 2 | 1 | 3,883 | 45 | 1,152 |
| Protein | Taxonomy | lu 25-109 (IC50) | lithium chloride (IC50) |
|---|---|---|---|
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 6.53 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderton, BH; Dayanandan, R; Forlenza, OV; Lovestone, S; Olesen, OF; Spink, JM | 1 |
1 other study(ies) available for lu 25-109 and lithium chloride
| Article | Year |
|---|---|
Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons.
Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Binding Sites; Calcium-Calmodulin-Dependent Protein Kinases; Carbachol; Cells, Cultured; Fetus; Glycogen Synthase Kinase 3; Glycogen Synthase Kinases; Lithium Chloride; Microtubules; Muscarinic Agonists; Neurons; Phosphorylation; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; tau Proteins; Tetrazoles; Thiadiazoles | 2000 |